Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 13/20 | 0.51 |
| ▸ | SRC | P12931 | 3/20 | 0.51 |
| ▸ | SIK2 | Q9H0K1 | 13/20 | 0.48 |
| ▸ | SIK3 | Q9Y2K2 | 13/20 | 0.48 |
| ▸ | SIK1 | P57059 | 11/20 | 0.48 |
| ▸ | BCR | P11274 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | PKMYT1 | Q99640 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23927260 | 0.84 | SIK2 (0.59) | ABL1SRCSIK2SIK3SIK1 | |
| SCHEMBL23927252 | 0.81 | SIK2 (0.61) | ABL1SRCSIK2SIK3SIK1 | |
| SCHEMBL23987729 | 0.76 | SIK2 (0.48) | ABL1SRCSIK2SIK3SIK1 | |
| SCHEMBL23927240 | 0.75 | SIK2 (0.62) | ABL1SRCSIK2SIK3SIK1 | |
| SCHEMBL23987735 | 0.69 | SIK2 (0.45) | ABL1SRCSIK2SIK3SIK1 | |
| SCHEMBL23927238 | 0.69 | ABL1 (0.71) | ABL1SRCSIK2SIK3SIK1 | |
| SCHEMBL19436378 | 0.68 | ABL1 (0.66) | ABL1SRCSIK2SIK3SIK1 | |
| SCHEMBL1147163 | 0.67 | ABL1 (1.00) | ABL1SRCSIK2SIK3SIK1 | |
| SCHEMBL29618220 | 0.67 | ABL1 (1.00) | ABL1SRCSIK2SIK3SIK1 | |
| SCHEMBL29352726 | 0.67 | ABL1 (1.00) | ABL1SRCSIK2SIK3SIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3901151-A1 | HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF | iOmx Therapeutics AG (DE) | 2021-10-27 | — | — | EP | disclosed |